Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| RenJi Hospital | OTHER |
| Shanghai Zhongshan Hospital | OTHER |
| Shanghai University of Traditional Chinese Medicine | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
This prospective study aims to investigate the role of IR-Seq in the diagnosis and disease monitoring in patients with IgA nephropathy.
Autoimmunity may play an important role in IgA nephropathy, and previous studies have shown that immune repertoire sequencing (IR-Seq) may help elucidate the dynamic changes of immune repertoire (IR) in autoimmune disease states. To further explore the potential application value of this technology, we will conduct a series of prospective studies to investigate the role of IR-Seq in the diagnosis and disease monitoring in patients with IgA nephropathy.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| IgAN patients at low risk of disease progression | n = 30, incipient disease |
| |
| IgAN patients at high risk of disease progression | n = 60, incipient disease |
| |
| Long-term stable patients | n = 30, follow-up for at least 15 years | ||
| Progressive IgAN patients | n = 30 | ||
| Healthy control | n = 30 |
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Intervention for incipient patients at low risk of disease progression | Drug | Conservative treatment, if necessary use ACEI/ARB and titrated to the maximum tolerated dose, with a BP-lowering goal of < 130/80 mm Hg |
| Measure | Description | Time Frame |
|---|---|---|
| Urinary protein remission rate | Including complete and partial remission rate of urinary protein. Complete remission criteria: post-treatment urine protein <0.3 g/24h; partial remission criteria: post-treatment urine protein <50% of the maximum value. | 24 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| 24-hour urine protein level | 24 weeks | |
| Serum albumin level | 24 weeks | |
| eGFR (estimated using the 2009 CKD-EPI formula) |
Not provided
Inclusion Criteria:
1. IgA nephropathy:
1) Long-term stable patients:
Follow-up for at least 15 years and meet at least one of the following:
Meet at least one of the following:
Exclusion Criteria:
Not provided
Not provided
Patients from Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, RenJi Hospital, Shanghai Zhongshan Hospital, Longhua Hospital Shanghai University of Traditional Chinese Medicine and Shanghai East Hospital
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Xinhua Hospital, Shanghai Jiao Tong University School of Medicine | Recruiting | Shanghai | China |
Not provided
Not provided
Not provided
Not provided
Serum samples; Blood samples taken using PAXgene vacuum blood collection tubes
| Intervention for patients at high risk of disease progression | Drug | BP-lowering goal of < 125/75 mm Hg and treat with steroids or steroids combined with immunosuppressants based on optimal supportive therapy:
|
|
| 24 weeks |
| ID | Term |
|---|---|
| D005922 | Glomerulonephritis, IGA |
| ID | Term |
|---|---|
| D005921 | Glomerulonephritis |
| D009393 | Nephritis |
| D007674 | Kidney Diseases |
| D014570 | Urologic Diseases |
| D052776 | Female Urogenital Diseases |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
| D052801 | Male Urogenital Diseases |
| D001327 | Autoimmune Diseases |
| D007154 | Immune System Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D008722 | Methods |
| ID | Term |
|---|---|
| D008919 | Investigative Techniques |
Not provided
Not provided